MD Anderson names new vice provost, clinical and interdisciplinary research
MD Anderson News Release 06/30/2015
鶹ӳ MD Anderson Cancer Center is pleased to announce the appointment of George Wilding, M.D., as vice provost for clinical and interdisciplinary research. Dr. Wilding’s appointment at MD Anderson will begin on September 1st.
Prior to joining MD Anderson, Dr. Wilding served on the institution’s external advisory board. He also served as chair of the Moon Shots...
Similarities between embryos and breast tumors identified
MD Anderson researchers find that metastatic tumors behave like embryonic stem cells
MD Anderson News Release 06/30/2015
Tiny particles in blood useful for early diagnosis of pancreatic cancer
MD Anderson study shows promise for Glypican-1 in identifying cancer-specific exosomes
MD Anderson News Release 06/24/2015
<...
Keys to prevention: MD Anderson leaders share latest news in fight to end cancer
Making Cancer History® seminar returns to Aspen July 16
MD Anderson News Release 06/24/2015
鶹ӳ MD Anderson Cancer Center heads to Aspen this summer for its 17th annual Making Cancer History® seminar. The free event is slated for 1-3 p.m. on July 16 at Aspen Meadows Resort’s Paepcke Auditorium, 1000 N. Third St.
Seating is limited. Registration is requested at 866-434-7084, press 5, or events...
Genomic discovery of skin cancer subtypes provides potential ‘signpost’ for drug targets
MD Anderson researchers lead The Cancer Genome Atlas analysis of cutaneous melanoma identifying four subtypes
MD Anderson News Release...
What’s in a name? “Death-associated protein” promotes cancer growth in most aggressive breast cancers
MD Anderson study identifies DAPK1 protein as a novel therapeutic target in tumors with TP53 mutations
MD Anderson News Release 06...
MD Anderson study finds gene mutations sensitize tumors to specific cancer drugs
Commonly mutated tumor suppressor represents a new target for treating certain cancers
MD Anderson News Release 06/11/2015
Yin and yang: Immune signaling protein has opposing roles in breast cancer development
MD Anderson study reveals the function of TLR4 in cancer growth depends on TP53 mutation
MD Anderson News Release 06/08/2015
...
Shelby Robin receives MD Anderson’s highest nursing honor
The Brown Foundation, Inc. honors cancer survivor for excellence in oncology nursing
MD Anderson News Release 06/04/2015
...
Houston Methodist Hospital, MD Anderson Cancer Center teams perform first multi-organ transplant that includes skull and scalp
MD Anderson News Release 06/04/2015
Surgical teams from Houston Methodist Hospital and 鶹ӳ MD Anderson...